Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+6.55M
-
Total reported value, excl. options
-
$313M
-
Value change
-
+$67.5M
-
Number of buys
-
57
-
Number of sells
-
-25
-
Price
-
$10.05
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2020
96 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q3 2020.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
of 84.7M outstanding shares and own 36.76% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.11M shares), BVF INC/IL (3.09M shares), RA CAPITAL MANAGEMENT, L.P. (2.12M shares), BlackRock Inc. (2.05M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.99M shares), SV Health Investors, LLC (1.82M shares), BAILLIE GIFFORD & CO (1.7M shares), Samsara BioCapital, LLC (1.68M shares), VANGUARD GROUP INC (1.3M shares), and CITADEL ADVISORS LLC (1.22M shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.